Once it reaches the tumor site, BLZ-945 conjugated albumin (BBLZ-945) could be released by BBLZ-945@PAC-PTX under the trigger of adenosine triphosphate (ATP) and then deplete TAMs.1083 An engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle (VIN) for treating ischemic stroke has been reported. Here, CXCL12 is linked to neoplasm.